Market Currents
Zogenix (ZGNX) resumes trading following its earlier trading halt ahead the FDA announcement on...
-
Friday, December 7, 2012, 8:02 PM ETZogenix (ZGNX) resumes trading following its earlier trading halt ahead the FDA announcement on Zohydro, and quickly craters 38%, currently at $1.50.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
